Share the post "GLENMARK LIFE SCIENCES Launches Offer for Sale, Debuting 11-07-2024!"
Glenmark Life Sciences Limited is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments. the company is entered into the public market through its Offer for Sale, set to launch from 11 Jul 2024 to 12 Jul 2024. with a face value of Rs2.00 per share,
| Security Name | GLENMARK LIFE SCIENCES LTD |
|---|---|
| Start Date | 11-07-2024 |
| End Date | 12-07-2024 |
| Offer Price () | |
| Face Value | 2.00 |
| Type Of Issue | OFS |
| Issue Status | Forthcoming |
| Security Type | Equity |
| Symbol | GLS |
| Issue Period | 11 Jul 2024 to 12 Jul 2024 |
| StartTime | 09:15 |
| EndTime | 15:30 |
| Offer Size – No. Of Shares | 96,17,371 |
| Offer Size For Retail Investors | 9,61,738 |
| Offer Size For Non Retail Investors | 86,55,633 |
| Floor Price | 810.00 |
| Lot Size | 1 |
| Tick Price | 0.05 |
| ISIN No | INE03Q201024 |
| Minimum Bid Quantity | 1 |
| Maximum Bid Quantity | 96,17,371 |
| Allocation Methodology | Price Priority |
| LTP | 878.95 |
| Selling Member | Kotak Securities Ltd |
| Seller Promoter | 1) Glenmark Pharmaceuticals Limited and 2) Glenn Mario Saldanha |
| Exchange Notices | 1) Opening of Offer for Sale for Glenmark Life Sciences Limited.2) Opening of Offer for Sale for GLENMARK LIFE SCIENCES LTD – Live Activities Schedule |
